Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B
The immunogenicity and safety of a new recombinant hepatitis B vaccine from the Instituto Butantan (Butang®) were evaluated in a multicenter, double-blind, prospective equivalence study in three centers in Brazil. Engerix B® was the standard vaccine. A total of 3937 subjects were recruited and 2754...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Fundação Oswaldo Cruz (FIOCRUZ)
2004-12-01
|
| Colección: | Memorias do Instituto Oswaldo Cruz |
| Materias: | |
| Acceso en línea: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000800014 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|